Practical Considerations for Cutting Edge Tech 2024

A deep dive into generative AI applications in I-O

Immuno-Oncology Insights 2024; 5(2), 41–49

DOI: 10.18609/ioi.2024.007

Published: 12 March
André Freitas

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with André Freitas, Senior Lecturer (University of Manchester) and Research Group Leader (Idiap Research Institute/National Biomarker Centre), about the intersection of generative AI and experimental cancer treatments, with a focus on clinical trials, regulatory considerations, and leveraging emerging technologies for a transformative impact in I-O.